News

ASCO Annual Meeting 2018

1-5 June 2018 | McCormick Place, Chicago | #ASCO18

Drug Repurposing as a Source of Innovative Therapies in Osteosarcoma

presented during the Sarcoma Poster Session on ASCO18

Annual Impact Sheet 2017

ReDO: selective PDE5 inhibitors as anti-cancer agents

Pantziarka, P., Sukhatme, V., Crispino, S., Bouche, G., Meheus, L., & Sukhatme, V. P. (2018). Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents. Ecancermedicalscience, 12, 824. doi:10.3332/ecancer.2018.824

Repurposing non-cancer drugs for breast cancer? An emerging opportunity.

presented on EBCC-11 by our colleague Sergio Crispino

11th European Breast Cancer Conference

21 – 23 March 2018 | Barcelona, Spain